Oncothyreon Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Oncothyreon (ONTY) Misses Q2 EPS by 3c
August 6, 2015 5:18 PM EDTOncothyreon (NASDAQ: ONTY) reported Q2 EPS of ($0.11), $0.03 worse than the analyst estimate of ($0.08).
As of June 30, 2015, Oncothyreon's cash, cash equivalents and investments were $70.0 million, compared to $63.7 million at December 31, 2014, an increase of $6.3 million, or 9.9 percent.
Oncothyreon currently expects operating expenses in... More
